{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:47:58Z","timestamp":1789188478084,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":208,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319582887","type":"print"},{"value":"9783319582900","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/164_2016_78","type":"book-chapter","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T08:50:35Z","timestamp":1477385435000},"page":"271-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Anti-angiogenic Therapy for Retinal Disease"],"prefix":"10.1007","author":[{"given":"Yannis M.","family":"Paulus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akrit","family":"Sodhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"issue":"3","key":"78_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1755-3768.2009.01700.x","volume":"89","author":"AM Abu El-Asrar","year":"2011","unstructured":"Abu El-Asrar AM, Struyf S, Verbeke H, Van Damme J, Geboes K (2011) Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes. Acta Ophthalmol 89(3):222\u2013228","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"78_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","volume":"118","author":"AP Adamis","year":"1994","unstructured":"Adamis AP, Miller JW, Bernal MT, D\u2019Amico DJ, Folkman J, Yeo TK, Yeo KT (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118(4):445\u2013450","journal-title":"Am J Ophthalmol"},{"issue":"22","key":"78_CR3","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331(22):1480\u20131487","journal-title":"N Engl J Med"},{"issue":"10","key":"78_CR4","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1097\/IAE.0b013e3182111669","volume":"31","author":"LP Aiello","year":"2011","unstructured":"Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD, Wolka AM, Shahri N, Milton RC, PKC-DRS and PKC-DRS2 Study Groups (2011) Oral protein kinase c \u03b2 inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the protein kinase C \u03b2 inhibitor-diabetic retinopathy study and the protein kinase C \u03b2 inhibitor-diabetic retinopathy study 2. Retina 31(10):2084\u20132094","journal-title":"Retina"},{"key":"78_CR5","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nm1095-1024","volume":"1","author":"T Alon","year":"1995","unstructured":"Alon T, Hemo I, Itin A, Pe\u2019er J, Stone J, Keshet E (1995) Vascular endothelial growth factor acts as a survival factor for new formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024\u20131028","journal-title":"Nat Med"},{"key":"78_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.4065\/81.9.1241","volume":"81","author":"RH Alvarez","year":"2006","unstructured":"Alvarez RH, Kantarjian HM, Cortes JE (2006) Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 81:1241\u20131257","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"78_CR7","first-page":"36","volume":"38","author":"RH Amin","year":"1997","unstructured":"Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW (1997) Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38(1):36\u201347","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"78_CR8","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nm.2186","volume":"16","author":"S Anand","year":"2010","unstructured":"Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN, Lapinski PE, King PD, Weis SM, Cheresh DA (2010) MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 16(8):909\u2013914","journal-title":"Nat Med"},{"key":"78_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/oxfordjournals.bmb.a070758","volume":"26","author":"N Ashton","year":"1970","unstructured":"Ashton N (1970) Retinal angiogenesis in the human embryo. Br Med Bull 26:103\u2013106","journal-title":"Br Med Bull"},{"issue":"6","key":"78_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1586\/14737140.2015.1042369","volume":"15","author":"C Aversa","year":"2015","unstructured":"Aversa C, Leone F, Zucchini G, Serini G, Geuna E, Milani A, Valdembri D, Martinello R, Montemurro F (2015) Linifanib: current status and future potential in cancer therapy. Expert Rev Anticancer Ther 15(6):677\u2013687","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"78_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113(3):363\u2013372","journal-title":"Ophthalmology"},{"issue":"23","key":"78_CR12","doi-asserted-by":"publisher","first-page":"E3030","DOI":"10.1073\/pnas.1423765112","volume":"112","author":"S Babapoor-Farrokhran","year":"2015","unstructured":"Babapoor-Farrokhran S, Jee K, Puchner B, Hassan SJ, Xin X, Rodrigues M, Kashiwabuchi F, Ma T, Hu K, Deshpande M, Daoud Y, Solomon S, Wenick A, Lutty GA, Semenza GL, Montaner S, Sodhi A (2015) Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy. Proc Natl Acad Sci U S A 112(23):E3030\u2013E3039","journal-title":"Proc Natl Acad Sci U S A"},{"key":"78_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00417-008-0819-2","volume":"246","author":"SJ Bakri","year":"2008","unstructured":"Bakri SJ, McCannel CA, Edwards AO, Moshfeghi DM (2008) Persistent ocular hypertension following intravitreal ranibizumab. Graefes Arch Clin Exp Ophthalmol 246:955\u2013958","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"78_CR14","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ophtha.2013.11.029","volume":"121","author":"SJ Bakri","year":"2014","unstructured":"Bakri SJ, Moshfeghi DM, Francom S, Rundle AC, Reshef DS, Lee PP, Schaeffer C, Rubio RG, Lai P (2014) Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials. Ophthalmology 121:1102\u20131108","journal-title":"Ophthalmology"},{"key":"78_CR15","doi-asserted-by":"publisher","first-page":"9391","DOI":"10.1073\/pnas.0812884106","volume":"106","author":"EM Barnett","year":"2009","unstructured":"Barnett EM, Zhang X, Maxwell D, Chang Q, Piwnica-Worms D (2009) Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc Natl Acad Sci U S A 106:9391\u20139396","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"78_CR16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1152\/jappl.1999.86.2.748","volume":"86","author":"JM Beach","year":"1999","unstructured":"Beach JM, Schwenzer KJ, Srinivas S, Kim D, Tiedeman JS (1999) Oximetry of retinal vessels by dual-wavelength imaging: calibration and influence of pigmentation. J Appl Physiol 86(2):748\u2013758","journal-title":"J Appl Physiol"},{"issue":"1","key":"78_CR17","doi-asserted-by":"publisher","first-page":"C25","DOI":"10.1152\/ajpcell.00084.2014","volume":"307","author":"A Birbrair","year":"2014","unstructured":"Birbrair A, Zhang T, Wang ZM, Messi ML, Olson JD, Mintz A, Delbono O (2014) Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol 307(1):C25\u2013C38","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"78_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/0301-4738.81023","volume":"59","author":"P Biswas","year":"2011","unstructured":"Biswas P, Sengupta S, Choudhary R, Home S, Paul A, Sinha S (2011) Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration. Indian J Ophthalmol 59(3):191\u2013196","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"78_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","volume":"116","author":"DM Brown","year":"2009","unstructured":"Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, ANCHOR Study Group (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116(1):57\u201365","journal-title":"Ophthalmology"},{"key":"78_CR20","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.022","volume":"117","author":"DM Brown","year":"2010","unstructured":"Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY, CRUISE Investigators (2010) Ranibizumab for macular edema after central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117:1124\u20131133","journal-title":"Ophthalmology"},{"issue":"9","key":"78_CR21","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1096\/fj.09-145102","volume":"24","author":"BA Bryan","year":"2010","unstructured":"Bryan BA, Dennstedt E, Mitchell DC, Walshe TE, Noma K, Loureiro R, Saint-Geniez M, Campaigniac JP, Liao JK, D\u2019Amore PA (2010) RhoA\/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis. FASEB J 24(9):3186\u20133195","journal-title":"FASEB J"},{"issue":"3","key":"78_CR22","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/dvdy.20184","volume":"231","author":"PH Burri","year":"2004","unstructured":"Burri PH, Hlushchuk R, Djonov V (2004) Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. Dev Dyn 231(3):474\u2013488","journal-title":"Dev Dyn"},{"key":"78_CR24","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ophtha.2010.02.021","volume":"117","author":"PA Campochiaro","year":"2010","unstructured":"Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG, BRAVO Investigators (2010) Ranibizumab for macular edema after branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117:1102\u20131112","journal-title":"Ophthalmology"},{"issue":"3","key":"78_CR25","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ophtha.2014.08.031","volume":"122","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA, Clark WL, Boyer DS, Heier JS, Brown DM, Vitti R, Kazmi H, Berliner AJ, Erickson K, Chu KW, Soo Y, Cheng Y, Haller JA (2015) Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study. Ophthalmology 122(3):538\u2013544","journal-title":"Ophthalmology"},{"issue":"5","key":"78_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nm848","volume":"9","author":"R Cao","year":"2003","unstructured":"Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y (2003) Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9(5):604\u2013613","journal-title":"Nat Med"},{"issue":"2","key":"78_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/jop.2012.0279","volume":"29","author":"ME Capozzi","year":"2013","unstructured":"Capozzi ME, Gordon AY, Penn JS, Jayagopal A (2013) Molecular imaging of retinal disease. J Ocul Pharmacol Ther 29(2):275\u2013286","journal-title":"J Ocul Pharmacol Ther"},{"key":"78_CR28","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1167\/iovs.10-6222","volume":"52","author":"C Caprara","year":"2011","unstructured":"Caprara C, Thiersch M, Lange C, Joly S, Samardzija M, Grimm C (2011) HIF1A is essential for the development of the intermediate plexus of the retinal vasculature. Invest Ophthalmol Vis Sci 52:2109\u20132117","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"20","key":"78_CR29","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","volume":"364","author":"DF Martin","year":"2011","unstructured":"CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364(20):1897\u20131908","journal-title":"N Engl J Med"},{"issue":"4","key":"78_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cmet.2013.09.003","volume":"18","author":"A Cerani","year":"2013","unstructured":"Cerani A, Tetreault N, Menard C, Lapalme E, Patel C, Sitaras N, Beaudoin F, Leboeuf D, De Guire V, Binet F, Dejda A, Rezende FA, Miloudi K, Sapieha P (2013) Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1. Cell Metab 18(4):505\u2013518","journal-title":"Cell Metab"},{"key":"78_CR31","unstructured":"Chakravarthy U, Adamis AP, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Patel M, VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group (2006) Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology 113(9):1508.e1\u201325"},{"issue":"9900","key":"78_CR32","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0140-6736(13)61501-9","volume":"382","author":"U Chakravarthy","year":"2013","unstructured":"Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Culliford LA, Reeves BC, IVAN study investigators (2013) Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet 382(9900):1258\u20131267","journal-title":"Lancet"},{"issue":"4","key":"78_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.survophthal.2015.11.006","volume":"61","author":"JH Chang","year":"2016","unstructured":"Chang JH et al (2016) Matrix metalloproteinase 14 modulates signal transduction and angiogenesis in the cornea. Surv Ophthalmol 61(4):478\u2013497","journal-title":"Surv Ophthalmol"},{"key":"78_CR34","first-page":"1201","volume":"36","author":"T Chan-Ling","year":"1995","unstructured":"Chan-Ling T, Gock B, Stone J (1995) The effect of oxygen on vasoformative cell division. Evidence that \u2018physiologic hypoxia\u2019 is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 36:1201\u20131214","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"78_CR35","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1167\/iovs.03-1169","volume":"45","author":"T Chan-Ling","year":"2004","unstructured":"Chan-Ling T, Mcleod DS, Hughes S, Bax-ter L, Chu Y, Hasegawa T, Lutty GA (2004) Astrocyte-endothelial cell relation-ships during human retinal vascular development. Invest Ophthalmol Vis Sci 45:2020\u20132032","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"78_CR37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1006\/jmbi.1999.3192","volume":"293","author":"Y Chen","year":"1999","unstructured":"Chen Y, Wiesmann C, Fuh G, Li B, Christinger HW, McKay P, de Vos AM, Lowman HB (1999) Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity matured Fab in complex with antigen. J Mol Biol 293:865\u2013881","journal-title":"J Mol Biol"},{"key":"78_CR38","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1096\/fj.00-0868fje","volume":"15","author":"Y Chu","year":"2001","unstructured":"Chu Y, Hughes S, Chan-Ling T (2001) Differentiation and migration of astrocyte precursor cells and astrocytes in human fetal retina: relevance to optic nerve coloboma. FASEB J 15:2013\u20132015","journal-title":"FASEB J"},{"key":"78_CR39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0014-4835(03)00153-2","volume":"77","author":"S Claxton","year":"2003","unstructured":"Claxton S, Fruttiger M (2003) Role of arteries in oxygen induced vaso-obliteration. Exp Eye Res 77:305\u2013311","journal-title":"Exp Eye Res"},{"issue":"3","key":"78_CR40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1634\/theoncologist.12-3-356","volume":"12","author":"MH Cohen","year":"2007","unstructured":"Cohen MH, Gootenberg J, Keegan P, Pazdur R (2007) FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer. Oncologist 12(3):356\u2013361","journal-title":"Oncologist"},{"key":"78_CR41","doi-asserted-by":"publisher","first-page":"13352","DOI":"10.1073\/pnas.0405479101","volume":"101","author":"MF Cordeiro","year":"2004","unstructured":"Cordeiro MF, Guo L, Luong V, Harding G, Wang W, Jones HE, Moss SE, Sillito AM, Fitzke FW (2004) Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci U S A 101:13352\u201313356","journal-title":"Proc Natl Acad Sci U S A"},{"key":"78_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-1-61779-080-5_24","volume":"731","author":"KM Coxon","year":"2011","unstructured":"Coxon KM, Duggan J, Cordeiro MF, Moss SE (2011) Purification of annexin V and its use in the detection of apoptotic cells. Methods Mol Biol 731:293\u2013308","journal-title":"Methods Mol Biol"},{"key":"78_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0165-5728(96)00103-8","volume":"70","author":"CA Cuff","year":"1996","unstructured":"Cuff CA, Martiney JA, Berman JW, Brosnan CF (1996) Differential effects of transforming growth factor-\u00df-1 on interleukin-1-induced cellular inflammation and vascular permeability in the rabbit retina. J Neuroimmunol 70:21\u201328","journal-title":"J Neuroimmunol"},{"key":"78_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.compbiolchem.2015.01.001","volume":"54","author":"YH Cui","year":"2015","unstructured":"Cui YH, Chen J, Xu T, Tian HL (2015) Structure-based grafting and identification of kinase-inhibitors to target mTOR signaling pathway as potential therapeutics for glioblastoma. Comput Biol Chem 54:57\u201365","journal-title":"Comput Biol Chem"},{"key":"78_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF00146764","volume":"41","author":"JG Cunha-Vaz","year":"1976","unstructured":"Cunha-Vaz JG (1976) The blood-retinal barriers. Doc Ophthalmol 41:287\u2013327","journal-title":"Doc Ophthalmol"},{"issue":"6","key":"78_CR46","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.ophtha.2006.02.027","volume":"113","author":"DJ D\u2019Amico","year":"2006","unstructured":"D\u2019Amico DJ, Masonson HN, Patel M, Adamis AP, Cunningham ET Jr, Guyer DR, Katz B, VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group (2006) Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 113(6):992\u20131001","journal-title":"Ophthalmology"},{"key":"78_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/bjophthalmol-2013-303117","volume":"98","author":"R Danis","year":"2014","unstructured":"Danis R, McLaughlin MM, Tolentino M, Staurenghi G, Ye L, Xu CF, Kim RY, Johnson MW, Group PEDS (2014) Pazopanib eye drops: a randomised trial in neovascular age-related macular degeneration. Br J Ophthalmol 98:172\u2013178","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"78_CR48","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.1424563112","volume":"112","author":"M Datta","year":"2015","unstructured":"Datta M, Via LE, Kamoun WS, Liu C, Chen W, Seano G, Weiner DM, Schimel D, England K, Martin JD, Gao X, Xu L, Barry CE 3rd, Jain RK (2015) Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery. Proc Natl Acad Sci U S A 112(6):1827\u20131832","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5425","key":"78_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1126\/science.285.5425.245","volume":"285","author":"DW Dawson","year":"1999","unstructured":"Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285(5425):245\u2013248","journal-title":"Science"},{"issue":"3","key":"78_CR50","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1364\/OL.35.000270","volume":"35","author":"A Zerda de la","year":"2010","unstructured":"de la Zerda A, Paulus YM, Teed R, Bodapati S, Dollberg Y, Khuri-Yakub BT, Blumenkranz MS, Moshfeghi DM, Gambhir SS (2010) Photoacoustic ocular imaging. Opt Lett 35(3):270\u2013272","journal-title":"Opt Lett"},{"issue":"12","key":"78_CR51","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1136\/bjo.2010.186361","volume":"95","author":"JR Oliveira Dias de","year":"2011","unstructured":"de Oliveira Dias JR, Rodrigues EB, Maia M, Magalh\u00e3es O Jr, Penha FM, Farah ME (2011) Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy. Br J Ophthalmol 95(12):1631\u20131637","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"78_CR52","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/IAE.0000000000000520","volume":"35","author":"VS Dedania","year":"2015","unstructured":"Dedania VS, Bakri SJ (2015) Sustained elevation of intraocular pressure after intravitreal anti-VEGF agents: what is the evidence? Retina 35(5):841\u2013858","journal-title":"Retina"},{"issue":"13","key":"78_CR53","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW (2015) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 372(13):1193\u20131203","journal-title":"N Engl J Med"},{"key":"78_CR54","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.chembiol.2011.07.005","volume":"18","author":"BC Dickinson","year":"2011","unstructured":"Dickinson BC, Tang Y, Chang Z, Chang CJ (2011) A nuclear-localized fluorescent hydrogen peroxide probe for monitoring sirtuin-mediated oxidative stress responses in vivo. Chem Biol 18:943\u2013948","journal-title":"Chem Biol"},{"issue":"7","key":"78_CR55","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2217\/nnm.13.106","volume":"8","author":"Y Ding","year":"2013","unstructured":"Ding Y, Li S, Nie G (2013) Nanotechnological strategies for therapeutic targeting of tumor vasculature. Nanomedicine (Lond) 8(7):1209\u20131222","journal-title":"Nanomedicine (Lond)"},{"key":"78_CR56","unstructured":"DiPietro LA (2016) Angiogenesis and wound repair: when enough is enough. J Leukoc Biol. pii: jlb.4MR0316-102R [Epub ahead of print]"},{"issue":"4","key":"78_CR57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/dvdy.10119","volume":"224","author":"VG Djonov","year":"2002","unstructured":"Djonov VG, Kurz H, Burri PH (2002) Optimality in the developing vascular system: branching remodeling by means of intussusception as an efficient adaptation mechanism. Dev Dyn 224(4):391\u2013402","journal-title":"Dev Dyn"},{"issue":"8","key":"78_CR58","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.ophtha.2012.02.010","volume":"119","author":"DV Do","year":"2012","unstructured":"Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS, da Vinci Study Group (2012) One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology 119(8):1658\u20131665","journal-title":"Ophthalmology"},{"issue":"1","key":"78_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jcp.21426","volume":"216","author":"J Doukas","year":"2008","unstructured":"Doukas J, Mahesh S, Umeda N, Kachi S, Akiyama H, Yokoi K, Cao J, Chen Z, Dellamary L, Tam B, Racanelli-Layton A, Hood J, Martin M, Noronha G, Soll R, Campochiaro PA (2008) Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema. J Cell Physiol 216(1):29\u201337","journal-title":"J Cell Physiol"},{"issue":"Suppl 5","key":"78_CR60","first-page":"739","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1991","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group (1991) Results from the early treatment diabetic retinopathy study. Ophthalmology 98(Suppl 5):739\u2013840","journal-title":"Ophthalmology"},{"issue":"6","key":"78_CR61","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.ophtha.2012.01.022","volume":"119","author":"DL Epstein","year":"2012","unstructured":"Epstein DL, Algvere PV, von Wendt G, Seregard S, Kvanta A (2012) Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study. Ophthalmology 119(6):1184\u20131189","journal-title":"Ophthalmology"},{"issue":"11","key":"78_CR62","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1021\/bc500400z","volume":"25","author":"SM Evans","year":"2014","unstructured":"Evans SM, Kim K, Moore CE, Uddin MI, Capozzi ME, Craft JR, Sulikowski GA, Jayagopal A (2014) Molecular probes for imaging of hypoxia in the retina. Bioconjug Chem 25(11):2030\u20132037","journal-title":"Bioconjug Chem"},{"issue":"19","key":"78_CR63","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1242\/dev.070037","volume":"138","author":"A Fantin","year":"2011","unstructured":"Fantin A, Schwarz Q, Davidson K, Normando EM, Denti L, Ruhrberg C (2011) The cytoplasmic domain of neuropilin 1 is dispensable for angiogenesis, but promotes the spatial separation of retinal arteries and veins. Development 138(19):4185\u20134191","journal-title":"Development"},{"issue":"4","key":"78_CR64","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1182\/blood-2005-11-4447","volume":"108","author":"B Favier","year":"2006","unstructured":"Favier B, Alam A, Barron P, Bonnin J, Laboudie P, Fons P, Mandron M, Herault JP, Neufeld G, Savi P, Herbert JM, Bono F (2006) Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood 108(4):1243\u20131250","journal-title":"Blood"},{"issue":"2","key":"78_CR65","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1167\/iovs.02-0040","volume":"44","author":"SA Feeney","year":"2003","unstructured":"Feeney SA, Simpson DA, Gardiner TA, Boyle C, Jamison P, Stitt AW (2003) Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression. Invest Ophthalmol Vis Sci 44(2):839\u2013847","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 3","key":"78_CR67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000088479","volume":"69","author":"N Ferrara","year":"2005","unstructured":"Ferrara N (2005) VEGF as a therapeutic target in cancer. Oncology 69(Suppl 3):11\u201316","journal-title":"Oncology"},{"key":"78_CR68","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","volume":"26","author":"N Ferrara","year":"2006","unstructured":"Ferrara N, Damico L, Shams N, Lowman H, Kim R (2006) Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26:859\u2013870","journal-title":"Retina"},{"key":"78_CR69","volume-title":"Angiogenesis: an integrative approach from science to medicine","year":"2008","unstructured":"Figg W, Folkman J (eds) (2008) Angiogenesis: an integrative approach from science to medicine. Springer, New York"},{"issue":"3","key":"78_CR70","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2174\/138920111794480606","volume":"12","author":"MI G\u00e1lvez","year":"2011","unstructured":"G\u00e1lvez MI (2011) Protein kinase C inhibitors in the treatment of diabetic retinopathy. Review. Curr Pharm Biotechnol 12(3):386\u2013391","journal-title":"Curr Pharm Biotechnol"},{"key":"78_CR71","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S1350-9462(02)00062-9","volume":"22","author":"RF Gariano","year":"2003","unstructured":"Gariano RF (2003) Cellular mechanisms in retinal vascular development. Prog Retin Eye Res 22:295\u2013306","journal-title":"Prog Retin Eye Res"},{"key":"78_CR72","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/nature04482","volume":"438","author":"RF Gariano","year":"2005","unstructured":"Gariano RF, Gardner TW (2005) Retinal angiogenesis in development and disease. Nature 438:960\u2013966","journal-title":"Nature"},{"issue":"2","key":"78_CR73","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.modgep.2005.06.008","volume":"6","author":"RF Gariano","year":"2006","unstructured":"Gariano RF, Hu D, Helms J (2006) Expression of angiogenesis-related genes during retinal development. Gene Expr Patterns 6(2):187\u2013192","journal-title":"Gene Expr Patterns"},{"issue":"6","key":"78_CR74","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1083\/jcb.200302047","volume":"161","author":"H Gerhardt","year":"2003","unstructured":"Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161(6):1163\u20131177","journal-title":"J Cell Biol"},{"issue":"4","key":"78_CR75","first-page":"340","volume":"6","author":"I Ghanem","year":"2014","unstructured":"Ghanem I, Riveiro ME, Paradis V, Faivre S, de Parga PM, Raymond E (2014) Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis. Am J Transl Res 6(4):340\u2013352","journal-title":"Am J Transl Res"},{"issue":"27","key":"78_CR77","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1056\/NEJMoa042760","volume":"351","author":"ES Gragoudas","year":"2004","unstructured":"Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351(27):2805\u20132816","journal-title":"N Engl J Med"},{"key":"78_CR78","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.exer.2003.11.008","volume":"78","author":"S Grisanti","year":"2004","unstructured":"Grisanti S, Canbek S, Kaiserling E, Adam A, Lafaut B, Gelisken F, Szurman P, Henke-Fahle S, Oficjalska-Mlynczak J, Bartz-Schmidt KU (2004) Expression of endoglin in choroidal neovascularization. Exp Eye Res 78:207\u2013213","journal-title":"Exp Eye Res"},{"issue":"1","key":"78_CR79","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ophtha.2013.08.015","volume":"121","author":"JE Grunwald","year":"2014","unstructured":"Grunwald JE, Daniel E, Huang J, Ying GS, Maguire MG, Toth CA, Jaffe GJ, Fine SL, Blodi B, Klein ML, Martin AA, Hagstrom SA, Martin DF, CATT Research Group (2014) Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 121(1):150\u2013161","journal-title":"Ophthalmology"},{"issue":"4","key":"78_CR80","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ophtha.2014.11.007","volume":"122","author":"JE Grunwald","year":"2015","unstructured":"Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Martin DF, Comparison of Age-related Macular Degeneration Treatments Trials Research Group (2015) Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 122(4):809\u2013816","journal-title":"Ophthalmology"},{"key":"78_CR81","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1350-9462(01)00010-6","volume":"20","author":"GS Hageman","year":"2001","unstructured":"Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch\u2019s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20:705\u2013732","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"78_CR82","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U, VIEW 1 and VIEW 2 Study Groups (2012) Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119(12):2537\u20132548","journal-title":"Ophthalmology"},{"key":"78_CR83","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-07-6307","volume":"68","author":"F Hilberg","year":"2008","unstructured":"Hilberg F, Roth GJ, Krssak M, Kautschitsch S, Sommergruber W, Tontsch-Grunt U, Garin-Chesa P, Bader G, Zoephel A, Quant J, Heckel A, Rettig WJ (2008) BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res 68:4774\u20134782","journal-title":"Cancer Res"},{"issue":"8","key":"78_CR84","doi-asserted-by":"crossref","first-page":"126","DOI":"10.19070\/2332-290X-1500027","volume":"3","author":"Z Hu","year":"2015","unstructured":"Hu Z, Wang X, Liu Q, Paulus YM (2015) Photoacoustic imaging in ophthalmology. Int J Ophthalmol Eye Sci 3(8):126\u2013132","journal-title":"Int J Ophthalmol Eye Sci"},{"issue":"32","key":"78_CR85","doi-asserted-by":"publisher","first-page":"E3325","DOI":"10.1073\/pnas.1412840111","volume":"111","author":"ME Hubbi","year":"2014","unstructured":"Hubbi ME, Gilkes DM, Hu H, Kshitiz, Ahmed I, Semenza GL (2014) Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1\u03b1 to promote cell-cycle progression. Proc Natl Acad Sci U S A 111(32):E3325\u2013E3334","journal-title":"Proc Natl Acad Sci U S A"},{"key":"78_CR86","first-page":"1217","volume":"41","author":"S Hughes","year":"2000","unstructured":"Hughes S, Yang H, Chan-Ling T (2000) Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci 41:1217\u20131228","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"78_CR87","first-page":"158","volume":"21","author":"A Jiang","year":"2005","unstructured":"Jiang A, Zhang M, Liu Z (2005) Angioblasts in adult and its role in ocular disorders due to neovascularization. Yan Ke Xue Bao 21(3):158\u2013162, 178","journal-title":"Yan Ke Xue Bao"},{"key":"78_CR88","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev.biochem.74.082803.133142","volume":"74","author":"WG Kaelin","year":"2005","unstructured":"Kaelin WG (2005) Proline hydroxylation and gene expression. Annu Rev Biochem 74:115\u2013128","journal-title":"Annu Rev Biochem"},{"key":"78_CR89","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/199146a0","volume":"199","author":"NS Kapany","year":"1963","unstructured":"Kapany NS, Peppers NA, Zweng HC, Flocks M (1963) Retinal photocoagulation by lasers. Nature 199:146\u2013149","journal-title":"Nature"},{"issue":"6","key":"78_CR90","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.preteyeres.2008.09.003","volume":"27","author":"C Kaur","year":"2008","unstructured":"Kaur C, Foulds WS, Ling EA (2008) Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res 27(6):622\u2013647","journal-title":"Prog Retin Eye Res"},{"key":"78_CR91","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1562\/LE-03-17.1","volume":"79","author":"A King","year":"2004","unstructured":"King A, Gottlieb E, Brooks DG, Murphy MP, Dunaief JL (2004) Mitochondria-derived reactive oxygen species mediate blue light-induced death of retinal pigment epithelial cells. Photochem Photobiol 79:470\u2013475","journal-title":"Photochem Photobiol"},{"issue":"3","key":"78_CR92","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/ncb1695","volume":"10","author":"T Kitamura","year":"2008","unstructured":"Kitamura T, Asai N, Enomoto A, Maeda K, Kato T, Ishida M, Jiang P, Watanabe T, Usukura J, Kondo T, Costantini F, Murohara T, Takahashi M (2008) Regulation of VEGF-mediated angiogenesis by the Akt\/PKB substrate Girdin. Nat Cell Biol 10(3):329\u2013337","journal-title":"Nat Cell Biol"},{"key":"78_CR93","doi-asserted-by":"publisher","first-page":"33577","DOI":"10.1074\/jbc.M605604200","volume":"281","author":"PP Knowles","year":"2006","unstructured":"Knowles PP, Murray-Rust J, Kjaer S, Scott RP, Hanrahan S, Santoro M, Ib\u00e1\u00f1ez CF, McDonald NQ (2006) Structure and chemical inhibition of the RET tyrosine kinase domain. J Biol Chem 281:33577\u201333587","journal-title":"J Biol Chem"},{"issue":"11","key":"78_CR94","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.ophtha.2013.06.020","volume":"120","author":"L Kodjikian","year":"2013","unstructured":"Kodjikian L, Souied EH, Mimoun G, Mauget-Fa\u00ffsse M, Behar-Cohen F, Decullier E, Huot L, Aulagner G, GEFAL Study Group (2013) Ranibizumab versus bevacizumab for neovascular age-related macular degeneration: results from the GEFAL noninferiority randomized trial. Ophthalmology 120(11):2300\u20132309","journal-title":"Ophthalmology"},{"issue":"1","key":"78_CR95","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ophtha.2013.08.012","volume":"121","author":"JF Korobelnik","year":"2014","unstructured":"Korobelnik JF, Holz FG, Roider J, Ogura Y, Simader C, Schmidt-Erfurth U, Lorenz K, Honda M, Vitti R, Berliner AJ, Hiemeyer F, Stemper B, Zeitz O, Sandbrink R, GALILEO Study Group (2014) Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 GALILEO study. Ophthalmology 121(1):202\u2013208","journal-title":"Ophthalmology"},{"issue":"5","key":"78_CR97","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.2337\/diabetes.54.5.1559","volume":"54","author":"JK Krady","year":"2005","unstructured":"Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, Levison SW (2005) Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54(5):1559\u20131565","journal-title":"Diabetes"},{"issue":"3","key":"78_CR98","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/bjophthalmol-2012-302391","volume":"97","author":"I Krebs","year":"2013","unstructured":"Krebs I, Schmetterer L, Boltz A, Told R, V\u00e9csei-Marlovits V, Egger S, Sch\u00f6nherr U, Haas A, Ansari-Shahrezaei S, Binder S, MANTA Research Group (2013) A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration. Br J Ophthalmol 97(3):266\u2013271","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"78_CR99","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4239\/wjd.v4.i6.310","volume":"4","author":"C Krispel","year":"2013","unstructured":"Krispel C, Rodrigues M, Xin X, Sodhi A (2013) Ranibizumab in diabetic macular edema. World J Diabetes 4(6):310\u2013318","journal-title":"World J Diabetes"},{"issue":"23","key":"78_CR100","first-page":"6737","volume":"60","author":"K Kuba","year":"2000","unstructured":"Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T (2000) HGF\/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res 60(23):6737\u20136743","journal-title":"Cancer Res"},{"key":"78_CR101","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/978-1-4614-3209-8_35","volume":"801","author":"T Kurihara","year":"2014","unstructured":"Kurihara T, Westenskow PD, Friedlander M (2014) Hypoxia-inducible factor (HIF)\/vascular endothelial growth factor (VEGF) signaling in the retina. Adv Exp Med Biol 801:275\u2013281","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"78_CR102","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ophtha.2015.01.007","volume":"122","author":"SH Kwon","year":"2015","unstructured":"Kwon SH, Shin JP, Kim IT, Park DH (2015) Aqueous levels of angiopoietin-like 4 and semaphorin 3E correlate with nonperfusion area and macular volume in diabetic retinopathy. Ophthalmology 122(5):968\u2013975","journal-title":"Ophthalmology"},{"issue":"1","key":"78_CR103","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1089\/scd.2008.0169","volume":"18","author":"EM Lad","year":"2009","unstructured":"Lad EM, Cheshier SH, Kalani MY (2009) Wnt-signaling in retinal development and disease. Stem Cells Dev 18(1):7\u201316","journal-title":"Stem Cells Dev"},{"issue":"12","key":"78_CR104","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1101\/gad.991402","volume":"16","author":"D Lando","year":"2002","unstructured":"Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK (2002) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16(12):1466\u20131471","journal-title":"Genes Dev"},{"issue":"1","key":"78_CR105","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5115\/acb.2012.45.1.38","volume":"45","author":"JH Lee","year":"2012","unstructured":"Lee JH, Park HS, Shin JM, Chun MH, Oh SJ (2012) Nestin expressing progenitor cells during establishment of the neural retina and its vasculature. Anat Cell Biol 45(1):38\u201346","journal-title":"Anat Cell Biol"},{"issue":"4","key":"78_CR106","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.neuroimage.2007.10.030","volume":"39","author":"Y Li","year":"2008","unstructured":"Li Y, Cheng H, Duong TQ (2008) Blood-flow magnetic resonance imaging of the retina. Neuroimage 39(4):1744\u20131751","journal-title":"Neuroimage"},{"key":"78_CR107","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1021\/bc900313d","volume":"21","author":"F Li","year":"2010","unstructured":"Li F, Liu J, Jas GS, Zhang J, Qin G, Xing J, Cotes C, Zhao H, Wang X, Diaz LA, Shi ZZ, Lee DY, Li KC, Li Z (2010) Synthesis and evaluation of a near-infrared fluorescent non-peptidic bivalent integrin alpha(v)beta(3) antagonist for cancer imaging. Bioconjug Chem 21:270\u2013278","journal-title":"Bioconjug Chem"},{"key":"78_CR108","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ophtha.2014.03.026","volume":"121","author":"X Li","year":"2014","unstructured":"Li X, Xu G, Wang Y, Xu X, Liu X, Tang S, Zhang F, Zhang J, Tang L, Wu Q, Luo D, Ke X, AURORA Study Group (2014a) Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study. Ophthalmology 121:1740","journal-title":"Ophthalmology"},{"key":"78_CR109","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.exer.2014.11.004","volume":"129","author":"YJ Li","year":"2014","unstructured":"Li YJ, Li XH, Wang LF, Kuang X, Hang ZX, Deng Y, Du JR (2014b) Therapeutic efficacy of a novel non-peptide \u03b1v\u03b23 integrin antagonist for pathological retinal angiogenesis in mice. Exp Eye Res 129:119\u2013126","journal-title":"Exp Eye Res"},{"issue":"35","key":"78_CR110","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2174\/138161210794455003","volume":"16","author":"S Liekens","year":"2010","unstructured":"Liekens S, Schols D, Hatse S (2010) CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization. Curr Pharm Des 16(35):3903\u20133920","journal-title":"Curr Pharm Des"},{"issue":"10","key":"78_CR111","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.1167\/iovs.11-8936","volume":"53","author":"M Lin","year":"2012","unstructured":"Lin M, Hu Y, Chen Y, Zhou KK, Jin J, Zhu M, Le YZ, Ge J, Ma JX (2012) Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization. Invest Ophthalmol Vis Sci 53(10):6197\u20136206","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"78_CR112","first-page":"1647","volume":"39","author":"RA Linsenmeier","year":"1998","unstructured":"Linsenmeier RA, Braun RD, McRipley MA, Padnick LB, Ahmed J, Hatchell DL, McLeod DS, Lutty GA (1998) Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci 39(9):1647\u20131657","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"78_CR113","doi-asserted-by":"publisher","first-page":"518426","DOI":"10.1155\/2012\/518426","volume":"2012","author":"R Longeras","year":"2012","unstructured":"Longeras R, Farjo K, Ihnat M, Ma JX (2012) A PEDF-derived peptide inhibits retinal neovascularization and blocks mobilization of bone marrow-derived endothelial progenitor cells. Exp Diabetes Res 2012:518426","journal-title":"Exp Diabetes Res"},{"issue":"2","key":"78_CR114","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/mt.2010.230","volume":"19","author":"M Lukason","year":"2011","unstructured":"Lukason M, DuFresne E, Rubin H, Pechan P, Li Q, Kim I, Kiss S, Flaxel C, Collins M, Miller J, Hauswirth W, Maclachlan T, Wadsworth S, Scaria A (2011) Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an AAV2 vector expressing a novel anti-VEGF molecule. Mol Ther 19(2):260\u2013265","journal-title":"Mol Ther"},{"key":"78_CR115","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/(SICI)1097-4547(19970801)49:3<268::AID-JNR2>3.0.CO;2-A","volume":"49","author":"JD Luna","year":"1997","unstructured":"Luna JD, Chan C-C, Derevjanik NL, Mahlow J, Chiu C, Peng B, Tobe T, Campochiaro PA, Vinores SA (1997) Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor, and interleukin-1\u00df-mediated breakdown. J Neurosci Res 49:268\u2013280","journal-title":"J Neurosci Res"},{"key":"78_CR116","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1749-6632.2002.tb04870.x","volume":"979","author":"A Luttun","year":"2002","unstructured":"Luttun A, Tjwa M, Carmeliet P (2002) Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Ann N Y Acad Sci 979:80\u201393","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"78_CR117","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/eye.2009.318","volume":"24","author":"GA Lutty","year":"2010","unstructured":"Lutty GA, Hasegawa T, Baba T, Grebe R, Bhutto I, McLeod DS (2010) Development of the human choriocapillaris. Eye (Lond) 24(3):408\u2013415","journal-title":"Eye (Lond)"},{"issue":"20","key":"78_CR119","doi-asserted-by":"publisher","first-page":"5448","DOI":"10.1182\/blood-2011-04-350173","volume":"118","author":"AC Ma","year":"2011","unstructured":"Ma AC, Fung TK, Lin RH, Chung MI, Yang D, Ekker SC, Leung AY (2011) Methionine aminopeptidase 2 is required for HSC initiation and proliferation. Blood 118(20):5448\u20135457","journal-title":"Blood"},{"issue":"21","key":"78_CR120","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","volume":"358","author":"AM Maguire","year":"2008","unstructured":"Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell\u2019Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J (2008) Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis. N Engl J Med 358(21):2240\u20132248","journal-title":"N Engl J Med"},{"issue":"20","key":"78_CR121","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1101\/gad.924501","volume":"15","author":"PC Mahon","year":"2001","unstructured":"Mahon PC, Hirota K, Semenza GL (2001) FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15(20):2675\u20132686","journal-title":"Genes Dev"},{"issue":"2","key":"78_CR123","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1182\/blood-2004-07-2958","volume":"105","author":"DJ Manalo","year":"2005","unstructured":"Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, Semenza GL (2005) Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105(2):659\u2013669","journal-title":"Blood"},{"key":"78_CR124","volume-title":"The development of the human eye","author":"IC Mann","year":"1928","unstructured":"Mann IC (1928) The development of the human eye. Cambridge University Press, Cambridge"},{"issue":"3","key":"78_CR125","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.critrevonc.2015.02.001","volume":"94","author":"C Marchetti","year":"2015","unstructured":"Marchetti C, Gasparri ML, Ruscito I, Palaia I, Perniola G, Carrone A, Farooqi AA, Pecorini F, Muzii L, Panici PB (2015) Advances in anti-angiogenic agents for ovarian cancer treatment: the role of trebananib (AMG 386). Crit Rev Oncol Hematol 94(3):302\u2013310","journal-title":"Crit Rev Oncol Hematol"},{"key":"78_CR126","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","volume":"119","author":"DF Martin","year":"2012","unstructured":"Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL (2012) Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 119:1388\u20131398","journal-title":"Ophthalmology"},{"issue":"11","key":"78_CR127","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.2174\/1389450111009011439","volume":"11","author":"JL Mauriz","year":"2010","unstructured":"Mauriz JL, Mart\u00edn-Renedo J, Garc\u00eda-Palomo A, Tu\u00f1\u00f3n MJ, Gonz\u00e1lez-Gallego J (2010) Methionine aminopeptidases as potential targets for treatment of gastrointestinal cancers and other tumours. Curr Drug Targets 11(11):1439\u20131457","journal-title":"Curr Drug Targets"},{"issue":"6","key":"78_CR128","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1113\/expphysiol.2005.030924","volume":"90","author":"PH Maxwell","year":"2005","unstructured":"Maxwell PH (2005) Hypoxia-inducible factor as a physiological regulator. Exp Physiol 90(6):791\u2013797","journal-title":"Exp Physiol"},{"issue":"6733","key":"78_CR129","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733):271\u2013275","journal-title":"Nature"},{"key":"78_CR130","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0026-2862(87)90021-5","volume":"33","author":"DS McLeod","year":"1987","unstructured":"McLeod DS, Lutty GA, Wajer SD, Flower RW (1987) Visualization of a developing vasculature. Microvasc Res 33:257\u2013269","journal-title":"Microvasc Res"},{"issue":"12","key":"78_CR131","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1002\/dvdy.20988","volume":"235","author":"DS McLeod","year":"2006","unstructured":"McLeod DS, Hasegawa T, Prow T, Merges C, Lutty G (2006) The initial fetal human retinal vasculature develops by vasculogenesis. Dev Dyn 235(12):3336\u20133347","journal-title":"Dev Dyn"},{"issue":"6","key":"78_CR132","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00417-012-1969-9","volume":"250","author":"DS McLeod","year":"2012","unstructured":"McLeod DS, Baba T, Bhutto IA, Lutty GA (2012) Co-expression of endothelial and neuronal nitric oxide synthases in the developing vasculatures of the human fetal eye. Graefes Arch Clin Exp Ophthalmol 250(6):839\u2013848","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"78_CR133","first-page":"137","volume":"68","author":"IC Michaelson","year":"1948","unstructured":"Michaelson IC (1948) The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc U K 68:137\u2013181","journal-title":"Trans Ophthalmol Soc U K"},{"issue":"6","key":"78_CR134","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ophtha.2005.02.007","volume":"112","author":"S Michels","year":"2005","unstructured":"Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS (2005) Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112(6):1035\u20131047","journal-title":"Ophthalmology"},{"key":"78_CR135","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.ophtha.2009.05.020","volume":"116","author":"K Miki","year":"2009","unstructured":"Miki K, Miki A, Matsuoka M, Muramatsu D, Hackett SF, Campochiaro PA (2009) Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor. Ophthalmology 116:1748\u20131754","journal-title":"Ophthalmology"},{"issue":"4","key":"78_CR136","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","volume":"118","author":"P Mitchell","year":"2011","unstructured":"Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A, RESTORE Study Group (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for DME. Ophthalmology 118(4):615\u2013625","journal-title":"Ophthalmology"},{"key":"78_CR137","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0065-2571(01)00037-1","volume":"42","author":"DR Mole","year":"2002","unstructured":"Mole DR, Pugh CW, Ratcliffe PJ, Maxwell PH (2002) Regulation of the HIF pathway: enzymatic hydroxylation of a conserved prolyl residue in hypoxia-inducible factor alpha subunits governs capture by the pVHL E3 ubiquitin ligase complex. Adv Enzyme Regul 42:333\u2013347","journal-title":"Adv Enzyme Regul"},{"issue":"2","key":"78_CR138","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/1566523043346453","volume":"4","author":"R Morishita","year":"2004","unstructured":"Morishita R, Aoki M, Hashiya N, Yamasaki K, Kurinami H, Shimizu S, Makino H, Takesya Y, Azuma J, Ogihara T (2004) Therapeutic angiogenesis using hepatocyte growth factor (HGF). Curr Gene Ther 4(2):199\u2013206","journal-title":"Curr Gene Ther"},{"key":"78_CR139","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ydbio.2011.12.027","volume":"363","author":"A Nakamura-Ishizu","year":"2012","unstructured":"Nakamura-Ishizu A, Kurihara T, Okuno Y, Ozawa Y, Kishi K, Goda N (2012) The formation of an angiogenic astrocyte template is regulated by the neuroretina in a HIF-1-dependent manner. Dev Biol 363:106\u2013114","journal-title":"Dev Biol"},{"key":"78_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.004","volume":"48","author":"H Nazari","year":"2015","unstructured":"Nazari H, Zhang L, Zhu D et al (2015) Stem cell based therapies for age-related macular degeneration: the promises and the challenges. Prog Retin Eye Res 48:1\u201339","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"78_CR142","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrd1955","volume":"5","author":"EW Ng","year":"2006","unstructured":"Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR, Adamis AP (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 5(2):123\u2013132","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"78_CR143","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","volume":"119","author":"QD Nguyen","year":"2012","unstructured":"Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS, RISE and RIDE Research Group (2012) Ranibizumab for DME: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119(4):789\u2013801","journal-title":"Ophthalmology"},{"key":"78_CR144","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1073\/pnas.0913154107","volume":"107","author":"Y Okubo","year":"2010","unstructured":"Okubo Y, Sekiya H, Namiki S, Sakamoto H, Iinuma S, Yamasaki M, Watanabe M, Hirose K, Iino M (2010) Imaging extrasynaptic glutamate dynamics in the brain. Proc Natl Acad Sci U S A 107:6526\u20136531","journal-title":"Proc Natl Acad Sci U S A"},{"key":"78_CR145","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0002-9440(10)64773-6","volume":"156","author":"H Ozaki","year":"2000","unstructured":"Ozaki H, Seo MS, Ozaki K, Yamada H, Yamada E, Okamoto N, Hofmann F, Wood JM, Campochiaro PA (2000) Blockage of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol 156:697\u2013707","journal-title":"Am J Pathol"},{"key":"78_CR146","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","volume":"15","author":"N Papadopoulos","year":"2012","unstructured":"Papadopoulos N, Martin J, Ruan Q, Rafique A, Rosconi MP, Shi E, Pyles EA, Yancopoulos GD, Stahl N, Wiegand SJ (2012) Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis 15:171\u2013185","journal-title":"Angiogenesis"},{"issue":"1","key":"78_CR147","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3892\/ijmm.2015.2202","volume":"36","author":"H Park","year":"2015","unstructured":"Park H, Lee DS, Yim MJ, Choi YH, Park S, Seo SK, Choi JS, Jang WH, Yea SS, Park WS, Lee CM, Jung WK, Choi IW (2015) 3,3\u2019-Diindolylmethane inhibits VEGF expression through the HIF-1\u03b1 and NF-kB pathways in human retinal pigment epithelial cells under chemical hypoxic conditions. Int J Mol Med 36(1):301\u2013308","journal-title":"Int J Mol Med"},{"issue":"1","key":"78_CR148","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/gt.2008.115","volume":"16","author":"P Pechan","year":"2009","unstructured":"Pechan P, Rubin H, Lukason M, Ardinger J, DuFresne E, Hauswirth WW, Wadsworth SC, Scaria A (2009) Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization. Gene Ther 16(1):10\u201316","journal-title":"Gene Ther"},{"key":"78_CR149","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1021\/nn303833p","volume":"6","author":"PM Peiris","year":"2012","unstructured":"Peiris PM, Toy R, Doolittle E, Pansky J, Abramowski A, Tam M, Vicente P, Tran E, Hayden E, Camann A, Mayer A, Erokwu BO, Berman Z, Wilson D, Baskaran H, Flask CA, Keri RA, Karathanasis E (2012) Imaging metastasis using an integrin-targeting chain-shaped nanoparticle. ACS Nano 6:8783\u20138795","journal-title":"ACS Nano"},{"issue":"3","key":"78_CR150","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/BF00920031","volume":"228","author":"PL Penfold","year":"1990","unstructured":"Penfold PL, Provis JM, Madigan MC, van Driel D, Billson FA (1990) Angiogenesis in normal human retinal development: the involvement of astrocytes and macrophages. Graefes Arch Clin Exp Ophthalmol 228(3):255\u2013263","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"78_CR151","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3928\/23258160-20130909-07","volume":"44","author":"S Pershing","year":"2013","unstructured":"Pershing S, Bakri SJ, Moshfeghi DM (2013) Ocular hypertension and intraocular pressure asymmetry after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina 44:460\u2013464","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"78_CR152","first-page":"2194","volume":"31","author":"DL Phelps","year":"1990","unstructured":"Phelps DL (1990) Oxygen and developmental retinal capillary remodeling in the kitten. Invest Ophthalmol Vis Sci 31:2194\u20132200","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"78_CR153","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","volume":"16","author":"M Presta","year":"2005","unstructured":"Presta M, Dell\u2019Era P, Mitola S, Moroni E, Ronca R, Rusnati M (2005) Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16:159\u2013178","journal-title":"Cytokine Growth Factor Rev"},{"key":"78_CR154","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1006\/exer.1997.0365","volume":"65","author":"JM Provis","year":"1997","unstructured":"Provis JM, Leech J, Diaz CM, Penfold PL, Stone J, Keshet E (1997) Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res 65:555\u2013568","journal-title":"Exp Eye Res"},{"issue":"4","key":"78_CR155","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000379754","volume":"53","author":"G Querques","year":"2015","unstructured":"Querques G, Capuano V, Frascio P, Bandello F, Souied EH (2015) Emerging therapeutic options in age-related macular degeneration. Ophthalmic Res 53(4):194\u2013199","journal-title":"Ophthalmic Res"},{"issue":"8","key":"78_CR156","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/archophthalmol.2012.393","volume":"130","author":"R Rajendram","year":"2012","unstructured":"Rajendram R, Fraser-Bell S, Kaines A, Michaelides M, Hamilton RD, Esposti SD, Peto T, Egan C, Bunce C, Leslie RD, Hykin PG (2012) A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol 130(8):972\u2013979","journal-title":"Arch Ophthalmol"},{"issue":"10011","key":"78_CR157","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/S0140-6736(15)00345-1","volume":"386","author":"EP Rakoczy","year":"2015","unstructured":"Rakoczy EP, Lai CM, Magno AL, Wikstrom ME, French MA, Pierce CM, Schwartz SD, Blumenkranz MS, Chalberg TW, Degli-Esposti MA, Constable IJ (2015) Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial. Lancet 386(10011):2395\u20132403","journal-title":"Lancet"},{"issue":"4","key":"78_CR158","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1172\/JCI31750","volume":"117","author":"PJ Ratcliffe","year":"2007","unstructured":"Ratcliffe PJ (2007) HIF-1 and HIF-2: working alone or together in hypoxia? J Clin Invest 117(4):862\u2013865","journal-title":"J Clin Invest"},{"key":"78_CR159","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1470-2045(13)70586-2","volume":"15","author":"M Reck","year":"2014","unstructured":"Reck M, Kaiser R, Mellemgaard A, Douillard JY, Orlov S, Krzakowski M, von Pawel J, Gottfried M, Bondarenko I, Liao M, Gann CN, Barrueco J, Gaschler-Markefski B, Novello S, LUME-Lung 1 Study Group (2014) Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Lancet Oncol 15:143\u2013155","journal-title":"Lancet Oncol"},{"issue":"5","key":"78_CR160","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/01.iae.0000225766.75009.3a","volume":"26","author":"RM Rich","year":"2006","unstructured":"Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G (2006) Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 26(5):495\u2013511","journal-title":"Retina"},{"key":"78_CR161","first-page":"1057","volume":"12","author":"LJ Rizzolo","year":"1997","unstructured":"Rizzolo LJ (1997) Polarity and the development of the outer blood-retinal barrier. Histol Histopathol 12:1057\u20131067","journal-title":"Histol Histopathol"},{"issue":"11","key":"78_CR162","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.2337\/db13-0014","volume":"62","author":"M Rodrigues","year":"2013","unstructured":"Rodrigues M, Xin X, Jee K, Babapoor-Farrokhran S, Kashiwabuchi F, Ma T, Bhutto I, Hassan SJ, Daoud Y, Baranano D, Solomon S, Lutty G, Semenza GL, Montaner S, Sodhi A (2013) VEGF secreted by hypoxic M\u00fcller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy. Diabetes 62(11):3863\u20133873","journal-title":"Diabetes"},{"issue":"14","key":"78_CR163","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419\u20131431","journal-title":"N Engl J Med"},{"issue":"15","key":"78_CR164","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1158\/1078-0432.CCR-14-2021","volume":"22","author":"M Roy-Luzarraga","year":"2016","unstructured":"Roy-Luzarraga M, Hodivala-Dilke K (2016) Molecular pathways: endothelial cell FAK-A target for cancer treatment. Clin Cancer Res 22(15):3718\u20133724","journal-title":"Clin Cancer Res"},{"key":"78_CR165","unstructured":"Rubio R (2014) Long-acting anti-VEGF delivery. Retina Today: 78\u201380"},{"issue":"4","key":"78_CR167","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1535-6108(03)00240-X","volume":"4","author":"MB Ruzinova","year":"2003","unstructured":"Ruzinova MB, Schoer RA, Gerald W, Egan JE, Pandolfi PP, Rafii S, Manova K, Mittal V, Benezra R (2003) Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4(4):277\u2013289","journal-title":"Cancer Cell"},{"issue":"12","key":"78_CR168","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1038\/eye.2008.423","volume":"23","author":"S Sacu","year":"2009","unstructured":"Sacu S, Michels S, Prager F, Weigert G, Dunavoelgyi R, Geitzenauer W, Pruente C, Schmidt-Erfurth U (2009) Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results. Eye (Lond) 23(12):2223\u20132227","journal-title":"Eye (Lond)"},{"issue":"4","key":"78_CR169","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018864","volume":"6","author":"H Salehi-Had","year":"2011","unstructured":"Salehi-Had H, Roh MI, Giani A, Hisatomi T, Nakao S, Kim IK, Gragoudas ES, Vavvas D, Guccione S, Miller JW (2011) Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization. PLoS One 6(4), e18864","journal-title":"PLoS One"},{"issue":"3","key":"78_CR170","doi-asserted-by":"publisher","first-page":"356","DOI":"10.4103\/0973-1482.119302","volume":"9","author":"CL Sampieri","year":"2013","unstructured":"Sampieri CL, Le\u00f3n-C\u00f3rdoba K, Remes-Troche JM (2013) Matrix metalloproteinases and their tissue inhibitors in gastric cancer as molecular markers. J Cancer Res Ther 9(3):356\u2013363","journal-title":"J Cancer Res Ther"},{"key":"78_CR171","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1006\/exer.1999.0730","volume":"69","author":"TM Sandercoe","year":"1999","unstructured":"Sandercoe TM, Madigan MC, Billson FA, Penfold PL, Provis JM (1999) Astrocyte proliferation during development of the human retinal vasculature. Exp Eye Res 69:511\u2013523","journal-title":"Exp Eye Res"},{"issue":"3","key":"78_CR173","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0002-9440(10)63448-7","volume":"163","author":"S Sarlos","year":"2003","unstructured":"Sarlos S, Rizkalla B, Moravski CJ, Cao Z, Cooper ME, Wilkinson-Berka JL (2003) Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin. Am J Pathol 163(3):879\u2013887","journal-title":"Am J Pathol"},{"issue":"2","key":"78_CR174","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/path.1278","volume":"199","author":"S Scarpino","year":"2003","unstructured":"Scarpino S, D\u2019Alena FC, Di Napoli A, Ballarini F, Prat M, Ruco LP (2003) Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis. J Pathol 199(2):243\u2013250","journal-title":"J Pathol"},{"issue":"5","key":"78_CR175","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrm1366","volume":"5","author":"CJ Schofield","year":"2004","unstructured":"Schofield CJ, Ratcliffe PJ (2004) Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5(5):343\u2013354","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"78_CR176","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.coph.2013.04.009","volume":"13","author":"CC Scholz","year":"2013","unstructured":"Scholz CC, Taylor CT (2013) Targeting the HIF pathway in inflammation and immunity. Curr Opin Pharmacol 13(4):646\u2013653","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"78_CR177","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/eye.2009.314","volume":"24","author":"AM Schor","year":"2010","unstructured":"Schor AM, Schor SL (2010) Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention. Eye (Lond) 24(3):450\u2013458","journal-title":"Eye (Lond)"},{"issue":"4","key":"78_CR179","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/jcb.21523","volume":"102","author":"GL Semenza","year":"2007","unstructured":"Semenza GL (2007) Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem 102(4):840\u2013847","journal-title":"J Cell Biochem"},{"issue":"3","key":"78_CR180","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"GL Semenza","year":"2012","unstructured":"Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148(3):399\u2013408","journal-title":"Cell"},{"issue":"6","key":"78_CR181","doi-asserted-by":"publisher","first-page":"066002","DOI":"10.1117\/1.JBO.21.6.066002","volume":"21","author":"D Sen","year":"2016","unstructured":"Sen D, SoRelle ED, Liba O, Dalal R, Paulus YM, Kim T-W, Moshfeghi DM, de la Zerda A (2016) High resolution contrast-enhanced optical coherence tomography in mice retinae. J Biomed Opt 21(6):066002","journal-title":"J Biomed Opt"},{"issue":"3","key":"78_CR182","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1167\/iovs.12-11055","volume":"54","author":"MJ Sheetz","year":"2013","unstructured":"Sheetz MJ, Aiello LP, Davis MD, Danis R, Bek T, Cunha-Vaz J, Shahri N, Berg PH, MBDL and MBCU Study Groups (2013) The effect of the oral PKC \u03b2 inhibitor ruboxistaurin on vision loss in two phase 3 studies. Invest Ophthalmol Vis Sci 54(3):1750\u20131757","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"78_CR183","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1172\/JCI17808","volume":"112","author":"SC Shih","year":"2003","unstructured":"Shih SC, Ju M, Liu N, Smith LE (2003) Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J Clin Invest 112(1):50\u201357","journal-title":"J Clin Invest"},{"key":"78_CR185","doi-asserted-by":"publisher","first-page":"13286","DOI":"10.1021\/ja902010p","volume":"131","author":"JR Simard","year":"2009","unstructured":"Simard JR, Getlik M, Gr\u00fctter C, Pawar V, Wulfert S, Rabiller M, Rauh D (2009) Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors. J Am Chem Soc 131:13286\u201313296","journal-title":"J Am Chem Soc"},{"issue":"1","key":"78_CR186","first-page":"101","volume":"35","author":"LE Smith","year":"1994","unstructured":"Smith LE, Wesolowski E, McLellan A, Kostyk SK, D\u2019Amato R, Sullivan R, D\u2019Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35(1):101\u2013111","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"78_CR187","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaophthalmol.2015.3723","volume":"133","author":"A Sodhi","year":"2015","unstructured":"Sodhi A, Montaner S (2015) Angiopoietin-like 4 as an emerging therapeutic target for diabetic Eye disease. JAMA Ophthalmol 133(12):1375\u20131376","journal-title":"JAMA Ophthalmol"},{"key":"78_CR189","volume":"8","author":"SD Solomon","year":"2014","unstructured":"Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS (2014) Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev 8, CD005139","journal-title":"Cochrane Database Syst Rev"},{"key":"78_CR190","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1172\/JCI0214362","volume":"109","author":"I Stalmans","year":"2002","unstructured":"Stalmans I, Ng YS, Rohan R, Fruttiger M, Bouch\u00e9 A, Yuce A, Fujisawa H, Hermans B, Shani M, Jansen S, Hicklin D, Anderson DJ, Gardiner T, Hammes HP, Moons L, Dewerchin M, Collen D, Carmeliet P, D\u2019Amore PA (2002) Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 109:327\u2013336","journal-title":"J Clin Invest"},{"issue":"1","key":"78_CR191","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0002-9394(14)75750-2","volume":"113","author":"E Stef\u00e1nsson","year":"1992","unstructured":"Stef\u00e1nsson E, Machemer R, de Juan E Jr, McCuen BW II, Peterson J (1992) Retinal oxygenation and laser treatment in patients with diabetic retinopathy. Am J Ophthalmol 113(1):36\u201338","journal-title":"Am J Ophthalmol"},{"key":"78_CR192","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","volume":"15","author":"J Stone","year":"1995","unstructured":"Stone J, Itin A, Alon T, Pe\u2019er J, Gnessin H, Chan-Ling T, Keshet E (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression in neuroglia. J Neurosci 15:4738\u20134747","journal-title":"J Neurosci"},{"issue":"3","key":"78_CR193","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10456-016-9510-0","volume":"19","author":"S Subhani","year":"2016","unstructured":"Subhani S, Vavilala DT, Mukherji M (2016) HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies. Angiogenesis 19(3):257\u2013273","journal-title":"Angiogenesis"},{"issue":"11","key":"78_CR194","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/eye.2010.147","volume":"24","author":"ML Subramanian","year":"2010","unstructured":"Subramanian ML, Abedi G, Ness S, Ahmed E, Fenberg M, Daly MK, Houranieh A, Feinberg EB (2010) Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial. Eye (Lond) 24(11):1708\u20131715","journal-title":"Eye (Lond)"},{"issue":"9","key":"78_CR195","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1096\/fj.14-251934","volume":"28","author":"D Sun","year":"2014","unstructured":"Sun D, Nakao S, Xie F, Zandi S, Bagheri A, Kanavi MR, Samiei S, Soheili ZS, Frimmel S, Zhang Z, Ablonczy Z, Ahmadieh H, Hafezi-Moghadam A (2014) Molecular imaging reveals elevated VEGFR-2 expression in retinal capillaries in diabetes: a novel biomarker for early diagnosis. FASEB J 28(9):3942\u20133951","journal-title":"FASEB J"},{"key":"78_CR196","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature08151","volume":"460","author":"A Takeda","year":"2009","unstructured":"Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K, Kaneko H, Albuquerque RJ, Dridi S, Saito K, Raisler BJ, Budd SJ, Geisen P, Munitz A, Ambati BK, Green MG, Ishibashi T, Wright JD, Humbles AA, Gerard CJ, Ogura Y, Pan Y, Smith JR, Grisanti S, Hartnett ME, Rothenberg ME, Ambati J (2009) CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460:225\u2013230","journal-title":"Nature"},{"issue":"3","key":"78_CR198","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.mvr.2011.09.001","volume":"82","author":"A Thakur","year":"2011","unstructured":"Thakur A, Scheinman RI, Rao VR, Kompella UB (2011) Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage. Microvasc Res 82(3):346\u2013350","journal-title":"Microvasc Res"},{"issue":"3","key":"78_CR199","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0002-9394(84)90316-7","volume":"98","author":"The Branch Vein Occlusion Study Group","year":"1984","unstructured":"The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98(3):271\u2013282","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"78_CR200","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0161-6420(81)34978-1","volume":"88","author":"The Diabetic Retinopathy Study Research Group","year":"1981","unstructured":"The Diabetic Retinopathy Study Research Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings. DRS report number 8. Ophthalmology 88(7):583\u2013600","journal-title":"Ophthalmology"},{"issue":"3","key":"78_CR201","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1586\/17512433.2014.890047","volume":"7","author":"B Todorich","year":"2014","unstructured":"Todorich B, Yiu G, Hahn P (2014) Current and investigational pharmacotherapeutic approaches for modulating retinal angiogenesis. Expert Rev Clin Pharmacol 7(3):375\u2013391","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"8","key":"78_CR202","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2174\/156652409789712783","volume":"9","author":"MJ Tolentino","year":"2009","unstructured":"Tolentino MJ (2009) Current molecular understanding and future treatment strategies for pathologic ocular neovascularization. Curr Mol Med 9(8):973\u2013981","journal-title":"Curr Mol Med"},{"issue":"3","key":"78_CR203","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1124\/pr.116.012492","volume":"68","author":"L Treps","year":"2016","unstructured":"Treps L, Conradi LC, Harjes U, Carmeliet P (2016) Manipulating angiogenesis by targeting endothelial metabolism: hitting the engine rather than the drivers \u2013 a new perspective? Pharmacol Rev 68(3):872\u2013887","journal-title":"Pharmacol Rev"},{"key":"78_CR204","volume-title":"Wolff\u2019s anatomy of the eye and orbit","author":"BJ Tripathi","year":"1997","unstructured":"Tripathi BJ, Tripathi RC (1997) Development of the human eye. In: Bron AJ, Tripathi RC, Tripathi BJ (eds) Wolff\u2019s anatomy of the eye and orbit, 8th edn. Chapman & Hall, London","edition":"8"},{"key":"78_CR205","doi-asserted-by":"publisher","first-page":"c2459","DOI":"10.1136\/bmj.c2459","volume":"340","author":"A Tufail","year":"2010","unstructured":"Tufail A, Patel PJ, Egan C, Hykin P, da Cruz L, Gregor Z, Dowler J, Majid MA, Bailey C, Mohamed Q, Johnston R, Bunce C, Xing W, ABC Trial Investigators (2010) Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ 340:c2459","journal-title":"BMJ"},{"issue":"2","key":"78_CR206","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1042\/CS20140390","volume":"129","author":"HE Tzeng","year":"2015","unstructured":"Tzeng HE, Chen PC, Lin KW, Lin CY, Tsai CH, Han SM, Teng CL, Hwang WL, Wang SW, Tang CH (2015) Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis. Clin Sci (Lond) 129(2):147\u2013158","journal-title":"Clin Sci (Lond)"},{"key":"78_CR207","unstructured":"Varner JA, Cheresh DA (1996) Tumor angiogenesis and the role of vascular cell integrin alphavbeta3. Important Adv Oncol 69\u201387"},{"key":"78_CR208","first-page":"141","volume":"10","author":"SA Vinores","year":"1995","unstructured":"Vinores SA (1995) Assessment of blood-retinal barrier integrity. Histol Histopathol 10:141\u2013154","journal-title":"Histol Histopathol"},{"issue":"3-4","key":"78_CR209","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/A:1002136712070","volume":"97","author":"SA Vinores","year":"1999","unstructured":"Vinores SA, Derevjanik NL, Ozaki H, Okamoto N, Campochiaro PA (1999) Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol 97(3-4):217\u2013228","journal-title":"Doc Ophthalmol"},{"key":"78_CR210","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1167\/iovs.02-1061","volume":"44","author":"JP Vrabec","year":"2003","unstructured":"Vrabec JP, Lieven CJ, Levin LA (2003) Cell-type-specific opening of the retinal ganglion cell mitochondrial permeability transition pore. Invest Ophthalmol Vis Sci 44:2774\u20132782","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"78_CR211","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92(12):5510\u20135514","journal-title":"Proc Natl Acad Sci U S A"},{"key":"78_CR212","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070544","volume":"8","author":"Q Wang","year":"2013","unstructured":"Wang Q, Li T, Wu Z, Wu Q, Ke X, Luo D, Wang H (2013) Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo. PLoS One 8, e70544","journal-title":"PLoS One"},{"issue":"10","key":"78_CR213","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1042\/CS20120212","volume":"124","author":"JL Wilkinson-Berka","year":"2013","unstructured":"Wilkinson-Berka JL, Rana I, Armani R, Agrotis A (2013) Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy. Clin Sci (Lond) 124(10):597\u2013615","journal-title":"Clin Sci (Lond)"},{"issue":"7","key":"78_CR214","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tips.2015.04.005","volume":"36","author":"P Wu","year":"2015","unstructured":"Wu P, Nielsen TE, Clausen MH (2015) FDA-approved small-molecule kinase inhibitors. Trends Pharmacol Sci 36(7):422\u2013439","journal-title":"Trends Pharmacol Sci"},{"key":"78_CR215","doi-asserted-by":"publisher","first-page":"429387","DOI":"10.1155\/2012\/429387","volume":"2012","author":"F Xie","year":"2012","unstructured":"Xie F, Luo W, Zhang Z, Sun D (2012) In vivo molecular imaging in retinal disease. J Ophthalmol 2012:429387","journal-title":"J Ophthalmol"},{"issue":"36","key":"78_CR216","doi-asserted-by":"publisher","first-page":"E3425","DOI":"10.1073\/pnas.1217091110","volume":"110","author":"X Xin","year":"2013","unstructured":"Xin X, Rodrigues M, Umapathi M, Kashiwabuchi F, Ma T, Babapoor-Farrokhran S, Wang S, Hu J, Bhutto I, Welsbie DS, Duh EJ, Handa JT, Eberhart CG, Lutty G, Semenza GL, Montaner S, Sodhi A (2013) Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. Proc Natl Acad Sci U S A 110(36):E3425\u2013E3434","journal-title":"Proc Natl Acad Sci U S A"},{"key":"78_CR217","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jconrel.2015.12.050","volume":"224","author":"F Yan","year":"2016","unstructured":"Yan F, Wu H, Liu H, Deng Z, Liu H, Duan W, Liu X, Zheng H (2016) Molecular imaging-guided photothermal\/photodynamic therapy against tumor by iRGD-modified indocyanine green nanoparticles. J Control Release 224:217\u2013228","journal-title":"J Control Release"},{"issue":"Pt 9","key":"78_CR218","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1242\/jcs.082834","volume":"124","author":"Y Yao","year":"2011","unstructured":"Yao Y, Tsirka SE (2011) Truncation of monocyte chemoattractant protein 1 by plasmin promotes blood-brain barrier disruption. J Cell Sci 124(Pt 9):1486\u20131495","journal-title":"J Cell Sci"},{"issue":"9","key":"78_CR219","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.molmed.2010.07.003","volume":"16","author":"X Ye","year":"2010","unstructured":"Ye X, Wang Y, Nathans J (2010) The Norrin\/Frizzled4 signaling pathway in retinal vascular development and disease. Trends Mol Med 16(9):417\u2013425","journal-title":"Trends Mol Med"},{"key":"78_CR220","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1350-9462(00)00027-6","volume":"20","author":"DY Yu","year":"2001","unstructured":"Yu DY, Cringle SJ (2001) Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res 20:175\u2013208","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"78_CR221","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3892\/ijo.2016.3400","volume":"48","author":"X Zhang","year":"2016","unstructured":"Zhang X, Huang S, Guo J, Zhou L, You L, Zhang T, Zhao Y (2016) Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review). Int J Oncol 48(5):1783\u20131793","journal-title":"Int J Oncol"},{"issue":"3","key":"78_CR222","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12519-014-0502-0","volume":"10","author":"AY Zhou","year":"2014","unstructured":"Zhou AY, Bai YJ, Zhao M, Yu WZ, Huang LZ, Li XX (2014) Placental growth factor expression is reversed by antivascular endothelial growth factor therapy under hypoxic conditions. World J Pediatr 10(3):262\u2013270","journal-title":"World J Pediatr"}],"container-title":["Handbook of Experimental Pharmacology","Pharmacologic Therapy of Ocular Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2016_78","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T15:55:40Z","timestamp":1558022140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2016_78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319582887","9783319582900"],"references-count":208,"URL":"https:\/\/doi.org\/10.1007\/164_2016_78","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"26 October 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}